Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.
Department of Anatomy, Histology and Embryology, Faculty of Medicine, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria.
Int J Mol Sci. 2024 Sep 18;25(18):10027. doi: 10.3390/ijms251810027.
Diabetic cardiomyopathy is a major etiological factor in heart failure in diabetic patients, characterized by mitochondrial oxidative metabolism dysfunction, myocardial fibrosis, and marked glycogen elevation. The aim of the present study is to evaluate the effect of endurance training and prebiotic xylooligosaccharide (XOS) on the activity of key oxidative enzymes, myocardial collagen, and glycogen distribution as well as some serum biochemical risk markers in streptozotocin-induced type 1 diabetic rats. Male Wistar rats (n = 36) were divided into four diabetic groups (n = 9): sedentary diabetic rats on a normal diet (SDN), trained diabetic rats on a normal diet (TDN), trained diabetic rats on a normal diet with an XOS supplement (TD-XOS), and sedentary diabetic rats with an XOS supplement (SD-XOS). The results show that aerobic training managed to increase the enzyme activity of respiratory Complex I and II and the lactate dehydrogenase in the cardiomyocytes of the diabetic rats. Furthermore, the combination of exercise and XOS significantly decreased the collagen and glycogen content. No significant effects on blood pressure, heart rate or markers of inflammation were detected. These results demonstrate the beneficial effects of exercise, alone or in combination with XOS, on the cardiac mitochondrial enzymology and histopathology of diabetic rats.
糖尿病性心肌病是糖尿病患者心力衰竭的主要病因,其特征为线粒体氧化代谢功能障碍、心肌纤维化和明显的糖原升高。本研究旨在评估耐力训练和益生元木寡糖(XOS)对链脲佐菌素诱导的 1 型糖尿病大鼠心脏关键氧化酶活性、心肌胶原和糖原分布以及一些血清生化风险标志物的影响。雄性 Wistar 大鼠(n = 36)分为四组糖尿病大鼠(n = 9):正常饮食的安静型糖尿病大鼠(SDN)、正常饮食的训练型糖尿病大鼠(TDN)、正常饮食加 XOS 补充的训练型糖尿病大鼠(TD-XOS)和 XOS 补充的安静型糖尿病大鼠(SD-XOS)。结果表明,有氧运动可增加糖尿病大鼠心肌细胞呼吸复合物 I 和 II 以及乳酸脱氢酶的酶活性。此外,运动和 XOS 的联合使用可显著降低胶原和糖原含量。血压、心率或炎症标志物无显著变化。这些结果表明,运动单独或与 XOS 联合使用可改善糖尿病大鼠的心脏线粒体酶学和组织病理学。
J Endocrinol. 2018-4
Cardiovasc Diabetol. 2013-9-24
Cardiovasc Diabetol. 2025-4-9
Rev Cardiovasc Med. 2024-5-16
J Mol Cell Cardiol. 2024-4
Front Pharmacol. 2022-8-26
Z Naturforsch C J Biosci. 2022-9-27
Front Cardiovasc Med. 2021-9-23
Front Physiol. 2021-8-17